Page last updated: 2024-08-26

peptide elongation factor 2 and dorsomorphin

peptide elongation factor 2 has been researched along with dorsomorphin in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, Y; Klann, E; Ma, T; Marambaud, P; Vingtdeux, V; Viollet, B; Zhao, H1

Other Studies

1 other study(ies) available for peptide elongation factor 2 and dorsomorphin

ArticleYear
Inhibition of AMP-activated protein kinase signaling alleviates impairments in hippocampal synaptic plasticity induced by amyloid β.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2014, Sep-03, Volume: 34, Issue:36

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; AMP-Activated Protein Kinases; Amyloid beta-Protein Precursor; Animals; Cells, Cultured; Elongation Factor 2 Kinase; Excitatory Postsynaptic Potentials; Female; Hippocampus; Humans; Long-Term Potentiation; Long-Term Synaptic Depression; Male; Mice; Mice, Inbred C57BL; Peptide Elongation Factor 2; Presenilin-1; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Signal Transduction

2014